on August 16, 2007
Published online before print August 16, 2007, doi: 10.1161/STROKEAHA.107.483255
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 25, 2007
From the Department of Neurology (P.D.S., M.K.), University of Erlangen, Erlangen, Germany; the Department of Neurology (P.D.S., M.K.), University of Heidelberg, Heidelberg, Germany; the Departments of Neurology (G.T.) and Neuroradiology (J.F.), University of Hamburg, Hamburg, Germany; the Department of Neurology (O.Z.-W., J.S.), University of Cologne, Cologne, Germany; the Department of Neurology (T.N.-H., O.C.S.), University of Frankfurt, Frankfurt, Germany; and the Department of Neurology (C.A.M., M.R.), Autonomic University of Barcelona–Hospital Vall d’Hebron, Barcelona, Spain. * To whom correspondence should be addressed. E-mail: Peter.Schellinger{at}uk-erlangen.de.
Background and Purpose—The use of intravenous thrombolysis is restricted to a minority of patients by the rigid 3-hour time window. This window may be extended by using modern imaging-based selection algorithms. We assessed safety and efficacy of MRI-based thrombolysis within and beyond 3 hours compared with standard CT-based thrombolysis. Methods—Five European stroke centers pooled the core data of their CT- and MRI-based prospective thrombolysis databases. Safety outcomes were predefined as symptomatic intracranial hemorrhage and mortality. Primary efficacy outcome was a favorable outcome (modified Rankin Scale 0 to 1). We performed univariate and multivariate analyses for all end points, including age, National Institutes of Health Stroke Scale, treatment group (CT <3 hours, MRI <3 hours and >3 hours), and onset to treatment time as variables. Results—A total of 1210 patients were included (CT <3 hours: N=714; MRI <3 hours: N=316; MRI >3 hours: N=180). Median age, National Institutes of Health Stroke Scale, and onset to treatment time were 69, 67, and 68.5 years (P=0.66); 12, 13, and 14 points (P=0.019); and 130, 135, and 240 minutes (P<0.001). Symptomatic intracranial hemorrhage rates were 5.3%, 2.8%, and 4.4% (P=0.213); mortality was 13.7%, 11.7%, and 13.3% (P=0.68). Favorable outcome occurred in 35.4%, 37.0%, and 40% (P=0.51). Age and National Institutes of Health Stroke Scale were independent predictors for all safety and efficacy outcomes. The overall use of MRI significantly reduced symptomatic intracranial hemorrhage (OR: 0.520, 95% CI: 0.270 to 0.999, P=0.05). Beyond 3 hours, the use of MRI significantly predicted a favorable outcome (OR: 1.467; 95% CI: 1.017 to 2.117, P=0.040). Within 3 hours and for all secondary end points, there was a trend in favor of MRI-based selection over standard <3-hour CT-based treatment. Conclusion—Despite significantly longer time windows and significantly higher baseline National Institutes of Health Stroke Scale scores, MRI-based thrombolysis is safer and potentially more efficacious than standard CT-based thrombolysis.
Revised on March 23, 2007
Accepted on March 27, 2007
MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows. An Analysis of 1210 Patients
Peter D. Schellinger MD, PhD*;
Key words: diffusion–perfusion mismatch • intravenous thrombolysis • MRI • stroke
This article has been cited by other articles:
 |
|
 |
|
  R Selvaratnam, U Srirangalingam, S Ahmad, and P Goulden Thrombolysis beyond 3 hours for acute ischaemic stroke Emerg. Med. J., October 1, 2009; 26(10): 756 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kohrmann and S. Schwab Response to Letter by Furlan Stroke, September 1, 2009; 40(9): e535 - e535. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Fiebach and P. D. Schellinger MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes Stroke, August 1, 2009; 40(8): 2906 - 2907. [Full Text] [PDF]
|
|
|
|
|
|
W.-R. Schabitz MR Mismatch Is Useful for Patient Selection for Thrombolysis: No Stroke, August 1, 2009; 40(8): 2908 - 2909. [Full Text] [PDF]
|
|
|
|
|
|
O. Zaro-Weber, W. Moeller-Hartmann, W.-D. Heiss, and J. Sobesky The Performance of MRI-Based Cerebral Blood Flow Measurements in Acute and Subacute Stroke Compared With 15O-Water Positron Emission Tomography: Identification of Penumbral Flow Stroke, July 1, 2009; 40(7): 2413 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kohrmann and P. D. Schellinger Acute Stroke Triage to Intravenous Thrombolysis and Other Therapies with Advanced CT or MR Imaging: Pro MR Imaging Radiology, June 1, 2009; 251(3): 627 - 633. [Full Text] [PDF]
|
|
|
|
|
|
A. J. Yoo, L. A. Verduzco, P. W. Schaefer, J. A. Hirsch, J. D. Rabinov, and R. G. Gonzalez MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization Stroke, June 1, 2009; 40(6): 2046 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fisher and V. Hachinski European Cooperative Acute Stroke Study III: Support for and Questions About a Truly Emerging Therapy Stroke, June 1, 2009; 40(6): 2262 - 2263. [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Copenhaver, J. Shin, S. Warach, J. A. Butman, J. L. Saver, and C. S. Kidwell Gradient echo MRI: Implementation of a training tutorial for intracranial hemorrhage diagnosis Neurology, May 5, 2009; 72(18): 1576 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kohrmann, R. Sauer, H. B. Huttner, T. Engelhorn, A. Doerfler, and P. D. Schellinger MRI Mismatch-Based Intravenous Thrombolysis for Isolated Cerebellar Infarction Stroke, May 1, 2009; 40(5): 1897 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Earnshaw, D. Jackson, R. Farkouh, and L. Schwamm Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis Stroke, May 1, 2009; 40(5): 1710 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-D. Heiss and A. G. Sorensen Advances in Imaging Stroke, May 1, 2009; 40(5): e313 - e314. [Full Text] [PDF]
|
|
|
|
|
|
M. Kohrmann and S. Schwab Is It Ethical to Have a Placebo Arm in Reperfusion Trials in the 3- to 6-Hour Time Window? No: Time Frame or Time Gain? Stroke, April 1, 2009; 40(4): 1543 - 1544. [Full Text] [PDF]
|
|
|
|
 |
|
 H.J. Cloft, A. Rabinstein, G. Lanzino, and D.F. Kallmes Intra-Arterial Stroke Therapy: An Assessment of Demand and Available Work Force AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 453 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mittal, Z. Wu, J. Neelavalli, and E.M. Haacke Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 232 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yagi, K. T. Kitazato, M. Uno, Y. Tada, T. Kinouchi, K. Shimada, and S. Nagahiro Edaravone, a Free Radical Scavenger, Inhibits MMP-9-Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator Stroke, February 1, 2009; 40(2): 626 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A-H. Cho, J. S. Kim, S.-J. Kim, S.-C. Yun, C.-G. Choi, H.-R. Kim, S. U. Kwon, D.-H. Lee, E.-K. Kim, D.-C. Suh, et al. Focal Fluid-Attenuated Inversion Recovery Hyperintensity Within Acute Diffusion-Weighted Imaging Lesions Is Associated With Symptomatic Intracerebral Hemorrhage After Thrombolysis Stroke, December 1, 2008; 39(12): 3424 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Schellinger and M. Kohrmann MRA/DWI Mismatch: A Novel Concept or Something One Could Get Easier and Cheaper? Stroke, September 1, 2008; 39(9): 2423 - 2424. [Full Text] [PDF]
|
|
|
|
|
|
C. Iosif, C. Oppenheim, D. Trystram, V. Domigo, and J.-F. Meder MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1314 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fiehler and on behalf of the BRASIL investigators Response to Letter by Vernooij et al Stroke, July 1, 2008; 39(7): e116 - e116. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Quinn and K. R. Lees Advances in Emerging Therapies 2007 Stroke, February 1, 2008; 39(2): 255 - 257. [Full Text] [PDF]
|
|
|
|
|
|
A. G. Sorensen and W.-D. Heiss Advances in Imaging 2007 Stroke, February 1, 2008; 39(2): 276 - 278. [Full Text] [PDF]
|
|